Phoenix Life Sciences International Announces John Taleo as Company's Global Head of Security

DENVER, CO, April 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life” or the “Company”), an adaptive healthcare solutions company, today announced that John Taleo has been appointed as the Company’s Global Head of Security.

In advance of his retirement in February 2018, Taleo served as Acting Commissioner of the Vanuatu Police Service and dedicated 40 years of his career to the force’s service. Prior to that role, he held several positions with the Maritime Security in the Pacific in New Zealand with his most prominent position being Deputy Commissioner of Police. Additionally, Taleo was the Director of Vanuatu Police College, Chief of Staff to the Office of the Police Commissioner, and Assistant Superintendent of Vanuatu Prison Services.

“Throughout his extensive career in security, John has worked with international leaders and government changes and has proven his dedication to security,” said Martin Tindall, Chief Executive Officer of Phoenix Life. “As we plan to expand our international operations, John’s tailored skillset will help drive success and security compliance as we transform global healthcare.”

Taleo has received several prestigious awards throughout his career recognizing his commitment to global safety and security. In 2006, the U.S. Coast Guard recognized him for his outstanding performance and he was awarded the Commissioner’s Commendation Award for Excellent Police Work. Taleo was also awarded the Vanuatu Service Medal, U.N. Marshall Recognition, 20th Anniversary Independence Medal, National Medal of Merit, Long Service & Good Conduct Medal, Overseas Service Medal, Vanuatu Silva Jubili Medal, and Commissioner's Commendation Advance Stage Award. Phoenix Life intends to apply Taleo’s comprehensive security experience to remaining fully compliant with national security regulations and legislation, as well as path the way for global distribution in full compliance with treaties and controls regarding cannabis for medical and research purposes.

“When working internationally and within the cannabis industry, security proves to be an extremely important part of company success,” said John Taleo, Global Head of Security of Phoenix Life. “I look forward to utilizing and strengthening my expertise as I work to keep Phoenix Life a secure and stable operation.”

To learn more about Phoenix Life Sciences International, please visit To learn more about Phoenix Life in Vanuatu and how to register for blood sugar screenings, please visit

About Phoenix Life Sciences International Limited

Phoenix Life Sciences International Limited is an adaptive healthcare solutions company. Our business is to advance research and integrate programs and manufacturing of products that target and treat diabetes, pain, cancer, and address psychological, gastrointestinal, autoimmune, neurological and sleep disorders. We strive to create partnerships and integrate these programs for human health into communities worldwide as part of our Global Health Initiative.


Information contained in this press release regarding Phoenix Life Sciences International, Limited and its subsidiaries, (the “Companies”) may constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements. The words “plan”, “forecast”, “anticipates”, “estimate”, “project”, “intend”, “expect”, “should”, “believe,” and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to, known and unknown risks, uncertainties and other factors which could cause the Company’s actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in the Company’s filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to the Companies herein are expressly qualified in their entirety by the above-mentioned cautionary statement. The Companies disclaim any obligation to update forward-looking statements contained in this press release, except as may be required by law.


These statements have not been evaluated by the FDA and therefore the products sold by Phoenix Life Sciences International are not available in the U.S.


Phoenix Life Sciences International does not sell or distribute any products in the United States that are in violation of the United States Controlled Substances Act (US.CSA). This company does not grow, sell, and distribute cannabis-based products in the United States and is solely involved with the legal distribution of medical cannabis-based products within certain international markets outside of the United States.


Contact Data